Soheil Tavakolpour
Soheil Tavakolpour is an expert in Dermatology at Dana-Farber Cancer Institute (United States). As of September 2026, ScienceLeadR ranks Soheil Tavakolpour in the top 1% of experts in the United States for Skin Diseases, Vesiculobullous. Soheil Tavakolpour has authored 130 publications, the most recent in 2025. SLR score: 415 (community average: 125). How the SLR is computed.
LeadR Profile
Dermatology
Subspecialties: Immunology - Oncology - Internal Medicine
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2015 - 2025
Number : 130
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Enhancing T cell infiltration in glioblastoma: a review article on challenges and therapeutic strategies. PMID 40961824 — cells, myeloid-derived suppressor cells, neoplasms, phenotype, glioblastoma, therapeutics, t-lymphocytes, interleukin-10 | Cancer Treat Res Commun | 2025 | 0 |
| The Prognosis of Granulomatosis With Polyangiitis: The Risk of Relapse and Mortality Based on Baseline Clinical Manifestations, Laboratory Findings, and Disease Severity: A Retrospective Cohort Study. PMID 40959191 — creatinine, mortality, laboratories, cohort studies, signs and symptoms, therapeutics, nervous system, demography, prognosis, granulomatosis with polyangiitis | Health Sci Rep | 2025 | 0 |
| Antigen-Fc fusion therapy reduces severity of a model of pemphigus vulgaris without systemic immunosuppression. PMID 40864682 — cells, autoantibodies, therapeutics, immunosuppression therapy, pemphigus, b-lymphocytes | Sci Transl Med | 2025 | 0 |
| Rituximab versus azathioprine in maintenance therapy of patients with granulomatosis with polyangiitis. PMID 40786576 — azathioprine, maintenance, rituximab, therapeutics, granulomatosis with polyangiitis | Caspian J Intern Med | 2025 | 0 |
| A CAR enhancer increases the activity and persistence of CAR T cells. PMID 39079964 — cells, neoplasms, biotechnology, b-cell maturation antigen, interleukin-2, therapeutics, memory, t-lymphocytes, enhancer elements, genetic, b-lymphocytes, receptors, interleukin-2, car-t cell | Nat Biotechnol Top journal | 2024 | 9 |
LeadR Networks
Main global connection map